Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Alvimopan. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 known ✓ | P35372 | 14/20 | 1.00 |
| ▸ | OPRD1 | P41143 | 14/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 11/20 | 1.00 |
| ▸ | KCNE1 | P15382 | 1/20 | 1.00 |
| ▸ | KCNQ1 | P51787 | 1/20 | 1.00 |
| ▸ | CACNA1C | Q13936 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alvimopan SCHEMBL19367975 | 1.00 | OPRM1 (1.00) | OPRM1OPRD1OPRK1KCNE1KCNQ1 | |
| Alvimopan SCHEMBL12188165 | 1.00 | OPRM1 (1.00) | OPRM1OPRD1OPRK1KCNE1KCNQ1 | |
| Alvimopan SCHEMBL16449956 | 1.00 | OPRM1 (1.00) | OPRM1OPRD1OPRK1KCNE1KCNQ1 | |
| Alvimopan SCHEMBL13913401 | 1.00 | OPRM1 (1.00) | OPRM1OPRD1OPRK1KCNE1KCNQ1 | |
| Alvimopan SCHEMBL14995531 | 1.00 | OPRM1 (1.00) | OPRM1OPRD1OPRK1KCNE1KCNQ1 | |
| Alvimopan SCHEMBL25348849 | 1.00 | OPRM1 (1.00) | OPRM1OPRD1OPRK1KCNE1KCNQ1 | |
| Alvimopan SCHEMBL49578 | 1.00 | OPRM1 (1.00) | OPRM1OPRD1OPRK1KCNE1KCNQ1 | |
| Alvimopan SCHEMBL5953724 | 1.00 | OPRM1 (1.00) | OPRM1OPRD1OPRK1KCNE1KCNQ1 | |
| Alvimopan SCHEMBL1477341 | 0.99 | OPRM1 (0.98) | OPRM1OPRD1OPRK1KCNE1KCNQ1 | |
| Alvimopan SCHEMBL8786261 | 0.99 | OPRM1 (0.98) | OPRM1OPRD1OPRK1KCNE1KCNQ1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017158615-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF [[2(S)-[[4(R)-(3-HYDROXY PHENYL)-3(R), 4-DIMETHYL-1 -PIPERIDINYL]METHYL]-1 -OXO-3-PHENYLPROPYL] AMINO]ACETIC ACID DIHYDRATE | MSN LABORATORIES PRIVATE LIMITED (IN) | 2017-09-21 | — | — | WO | disclosed |